HomeInsights52 Week High Stocks

Glenmark Pharmaceuticals Ltd 52 Week High

Glenmark Pharmaceuticals Ltd 52 Week High

stocks purchased

₹ 0.7 Cr

Volume Transacted

(Nov 22, 2024)

stocks purchased

5.0 K

Stocks Traded

(Nov 22, 2024)

Last Updated on: Nov 23, 2024

Image

Glenmark Pharmaceuticals Ltd

NSE: GLENMARK

YEARHIGH

₹ 1830.05

Last updated on: Nov 22, 2024

Key Highlights

  • The 52 Week HIGH of Glenmark Pharmaceuticals Ltd is ₹ 1830 as of 22 Nov 24 .

Company Fundamentals for Glenmark Pharmaceuticals Ltd

No data available

Market Price of Glenmark Pharmaceuticals Ltd

1M

1Y

3Y

5Y

Monitoring Glenmark Pharmaceuticals Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
22 Nov 20241480.05
21 Nov 20241465.3
19 Nov 20241492.35
18 Nov 20241483.5
14 Nov 20241531.7
13 Nov 20241538.5
12 Nov 20241577.25
11 Nov 20241634.7
08 Nov 20241665.5
07 Nov 20241657.7

Asset Value vs Market Value of Glenmark Pharmaceuticals Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Historical Revenue of Glenmark Pharmaceuticals Ltd

No data available

* All values are in crore

Historical Net Profit of Glenmark Pharmaceuticals Ltd

No data available

* All values are in crore

Glenmark Pharmaceuticals Ltd News Hub

News

Glenmark Pharmaceuticals Ltd eases for fifth straight session

Glenmark Pharmaceuticals Ltd dropped for a fifth straight session today. The stock is quot...

Read more

18 Nov 202413:35

News

Glenmark Pharma reports turnaround Q2 results

Revenue from operations increased 2.29% year on year (YoY) to Rs 3,133.79 crore in the qua...

Read more

15 Nov 202414:40

News

Glenmark Pharmaceuticals Ltd gains for third straight session

Glenmark Pharmaceuticals Ltd gained for a third straight session today. The stock is quoti...

Read more

06 Nov 202413:05

News

Glenmark Pharmaceuticals declare Quarterly Result

Glenmark Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 1...

Read more

31 Oct 202412:07

News

Glenmark Pharmaceuticals Ltd spurts 2.21%

Glenmark Pharmaceuticals Ltd is up for a third straight session today. The stock is quotin...

Read more

08 Oct 202413:05

News

Glenmark Pharma spurts as Maharashtra facility clears USFDA inspection

The inspection was conducted from 9 September to 20 September 2024. In conclusion, the US ...

Read more

23 Sep 202410:12

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for 52 Week High of Glenmark Pharmaceuticals Ltd

What is the significance of Glenmark Pharmaceuticals Ltd reaching its 52-week high?

Glenmark Pharmaceuticals Ltd reaching its 52-week high indicates strong market confidence and a positive outlook on the company's financial health and growth prospects. This milestone often reflects successful business performance and can boost investor sentiment.

Why do investors monitor Glenmark Pharmaceuticals Ltd 52-week high?

Investors monitor Glenmark Pharmaceuticals Ltd 52-week high to gauge the stock's peak performance and overall market strength, which can indicate robust financial health and growth potential. It also helps them assess if the stock is trading near its maximum value, influencing decisions on buying, holding, or selling.

Is Glenmark Pharmaceuticals Ltd a good buy when it hits its 52-week high?

Whether Glenmark Pharmaceuticals Ltd is a good buy at its 52-week high depends on various factors, including the company's future growth prospects, overall market conditions, individual investment strategies, and other important Glenmark Pharmaceuticals Ltd fundamentals.

What should I consider before investing in Glenmark Pharmaceuticals Ltd at its 52-week high?

Before investing in Glenmark Pharmaceuticals Ltd at its 52-week high, consider evaluating the company's recent financial performance, growth potential, and overall market conditions to ensure it aligns with your investment goals. Additionally, assess whether the stock's current valuation justifies the potential for future returns and if it fits your risk tolerance.

Can Glenmark Pharmaceuticals Ltd stock price continue to rise after reaching its 52-week high?

Glenmark Pharmaceuticals Ltd stock price can continue to rise after reaching its 52-week high if it maintains strong fiscal performance and favorable market conditions. However, future growth depends on numerous factors such as company earnings, industry trends, and broader economic conditions.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199*